JCCI.co.uk

Eurogentec, a custom service and contract manufacturing company, announced today that its Seraing, Belgium Drug Substance manufacturing facility has recently completed a Pre-Approval Inspection (PAI) by the U.S. Food & Drug Administration (FDA) and that it has been granted "acceptable" status under the FDA's current regulatory guidelines.

SERAING, Belgium--(BUSINESS WIRE)--Eurogentec announced today that it has successfully completed a US FDA Pre-Approval Inspection (PAI) and that it will start commercial manufacturing of a biologic for the USA market.

A10 has built a solid business in the application delivery controller (ADC) market, but its platform also supports IPv6 migration and many cloud requirements, nicely positioning the company for the future. Network World Editor in Chief John Dix recently sat down with A10 founder and CEO Lee Chen for a company update. Chen, who was co-founder of Foundry Networks, says A10 already has 1,700 ...